Joseph Scodari

Joseph Scodari

Director/Board Member bei ACURX PHARMACEUTICALS, INC.

Vermögen: 53 134 $ am 31.03.2024

71 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Joseph C.
Scodari
currently works at Janssen, Inc., as Group Chairman, OptiNose US, Inc., as Chairman from 2017, Acurx Pharmaceuticals, Inc., as Independent Director from 2021, and Rutgers Robert Wood Johnson Medical School, as Member-Overseers Board.
Mr. Scodari also formerly worked at Johnson & Johnson, as Chairman-Worldwide Pharmaceuticals Group from 2005 to 2008, Biotechnology Innovation Organization, as Vice Chairman from 2003 to 2008, OptiNose, Inc., as Independent Chairman from 2017 to 2023, Ortho-McNeil Pharmaceutical LLC, as Group Chairman, Life Sciences Pennsylvania, as Chairman, Janssen Pharmaceutica NV, as Group Chairman, Pharmacyclics LLC, as Director, Labcorp Drug Development, Inc., as Independent Director from 2009 to 2015, Endo Health Solutions, Inc., as Independent Director from 2011 to 2013, Actelion Ltd., as Director from 2009 to 2011, Endo Pharmaceuticals, Inc., as Director, the University of the Sciences in Philadelphia, as Director, National Pharmaceutical Council, as Director, Actelion Pharmaceuticals Ltd., as Director, Centocor, Inc., as President & Chief Operating Officer from 1998 to 1999, Northwest Regional Development Agency, as Associate Member, Sterling Drug, Inc., as Vice President-Strategic Marketing, Rhone Poulenc Rorer, as Vice President-Marketing & Business Development, and Gwynedd-Mercy College, as Trustee.
Mr. Scodari received his undergraduate degree from Youngstown State University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.04.2023 31 230 ( 0,03% ) 45 596 $ 31.03.2024
15.06.2023 3 077 ( 0,02% ) 7 539 $ 31.03.2024

Aktive Positionen von Joseph Scodari

UnternehmenPositionBeginn
ACURX PHARMACEUTICALS, INC. Director/Board Member 24.06.2021
Chairman 01.10.2017
Corporate Officer/Principal 25.03.2010
Rutgers Robert Wood Johnson Medical School Corporate Officer/Principal -
Alle aktiven Positionen von Joseph Scodari

Ehemalige bekannte Positionen von Joseph Scodari

UnternehmenPositionEnde
OPTINOSE, INC. Chairman 08.06.2023
COVANCE INC. Director/Board Member 19.02.2015
Director/Board Member 31.12.2013
ACTELION Chairman 20.07.2009
JOHNSON & JOHNSON Chairman 01.03.2005
Sehen Sie sich die Erfahrung von Joseph Scodari im Detail an

Ausbildung von Joseph Scodari

Youngstown State University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joseph Scodari im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
JOHNSON & JOHNSON

Health Technology

OPTINOSE, INC.

Health Technology

ACURX PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen17

Health Technology

Health Technology

Health Technology

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Sterling Drug, Inc.

Consumer Non-Durables

Process Industries

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Joseph Scodari